Novo Holdings led the Series A investment in Kivu Biosciences, developer of next-generation antibody drug conjugates for solid tumors. The startup’s ADCs and technology were licensed from Synaffix, a Lonza subsidiary. The post Precision Oncology Startup Kivu Unveils $92M for More Stable & Durable ADC Cancer Drugs appeared first on MedCity News.
In this month’s episode, Senior Reporter Katie Adams discussed some of the executive moves, exits and layoffs that recently occurred in the healthcare world. She also interviewed Amy Abernethy, who recently co-founded Highlander Health with fellow healthcare veteran Brad Hirsch. The post MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Amy Abernethy, Co-Founder…
Sponsored by Personify Health, a leader in personalized health platforms, the webinar draws attention to a variety of perspectives, including a CFO, a former CHRO, a chief medical officer and a health benefits research director. The post 5 Takeaways from Personify Health Webinar on Battling Rising Costs of Healthcare appeared first on MedCity News.
A strategic orientation that leans into emerging value, even when this challenges our assumptions about who we are and what we do and the niche we do it in, enables organizations to make distinctive contributions sought by others. The post Magic Feedback Loops for Renewable Value in Healthcare Leadership appeared first on MedCity News.
For those who rely on these treatments, affordable medication access is a matter of health, freedom, and dignity, and their mechanisms and outcomes are non-partisan. The post Financial Security, Lasting Relief: How the Inflation Reduction Act Restores Health to Patients and Hope to Their Doctors appeared first on MedCity News.
After the FDA delayed the approval of MDMA-assisted therapy for PTSD, there’s still a way forward for psychedelic medicines, experts said at HLTH. The post What’s Next for Psychedelic Medicines? appeared first on MedCity News.
The FDA had asked Biogen and Sage Therapeutics to provide more clinical data supporting Zurzuvae in major depressive disorder. Citing the time and expense of additional clinical trials, the partners decided against further development in this indication The post Biogen, Sage Therapeutics Drop Plans to Develop Partnered Drug in Major Depressive Disorder appeared first on…
Most Americans don’t understand how an administration’s view on healthcare data sharing interoperability could directly impact them, pointed out Arcadia CEO Michael Meucci. More requirements around data sharing could lead to better care continuity, improved outcomes and lower costs. The post What Could the Election Mean for Data Interoperability? appeared first on MedCity News.
The status quo is simply untenable for many companies as health insurance costs spiral. From family-owned businesses to large enterprises, employers are taking advantage of an alternative designed by politicians on both sides of the aisle. The post How a Bipartisan Program Can Help You Avoid Costly Health Insurance Renewals appeared first on MedCity News.
Truth is, there are hugely positive tailwinds at our back. But the way we’ve been thinking about the problem is holding us back from solving it. Here’s why. The post Dear Mr. Buffett: Healthcare Isn’t Hopeless appeared first on MedCity News.